Hide Board Information

Show Board Information

Warren Resources Inc. WRESQ

Board Mod: Serial Investor

Asst Mods:

Last Post: 12/01/2014 1:13:13 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 10

Warren Resources Inc. (NASDAQ: WRES)

Company Website: http://www.warrenresources.com/

Warren Resources Inc. (NASDAQ: WRESQ) Stock Message Board

1. WRESQ Company Profile

    

2. WRESQ Time & Sales

    

3. WRESQ Recent News

    

4. WRESQ Filings

    

5. WRESQ Financials

    

6. WRESQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	WRES up +4.39% percent Today $WRES Stock High is	Lucky Jimmy	12/01/2014 1:13:13 PM
6	WRES 2.62 Warren Resources $WRES Hit a 52 week	Emylers	11/26/2014 11:27:25 AM
5	WRES 2.82 Warren Resources $WRES Hit a 52 week	Emylers	11/25/2014 11:08:19 AM
4	WRES 2.94 Warren Resources $WRES Hit a 52 week	Emylers	11/18/2014 11:35:22 AM
3	Latest Warren Resources (WRES) Headlines Apache	Stock_Tracker	03/13/2014 3:54:18 PM
2	WRES Stock Charts Last: +0.23 Sunday, March 2,	chartguy89	03/02/2014 12:22:49 AM
1	WRES Stock Charts Last: +0.17 Friday, February	chartguy89	02/28/2014 7:52:52 AM

Recent Articles

• Legal Action Launched for Kyverna Therapeutics Investors
• Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
• Haloid Enhances Safety in Film Productions with Reviews
• Insights on the Growing Demand for Edible Coatings in Produce
• Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
• Legal Update: Toronto-Dominion Bank Securities Class Action
• Key Updates from Nasdaq on the Nasdaq-100 Index Changes
• TeraBox Revolutionizes File Sharing with Free Unlimited Service
• Kessler Topaz Takes Action Against Enphase Energy for Fraud
• Demesne Resources Completes Second Tranche of Financing
• Spiro Celebrated as One of the Top Agencies in Marketing
• Global Uranium Corp. Launches Strategic Marketing Efforts
• UnitedHealth Group Clarifies Misconceptions and Updates Claims
• Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
• Acadia Healthcare Investors Urged to Take Action on Lawsuit
• Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
• Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
• Hola Prime's Innovative Vision: New Marketing Director Appointed
• Teamsters Advocate for Stronger Standards on Autonomous Vehicles
• BioVaxys Secures Funding and Enters Debt Settlement Agreement
• Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment
• OFS Credit Company Shares November Net Asset Value Insights
• New FDA Approval for Crenessity Enhances CAH Treatment Options
• Q-Gold Secures Initial Funding for New Exploration Ventures
• Capital Power's Genesee Project Marks Major Energy Milestone
• Viridian Therapeutics Set to Present Veligrotug Results Soon
• Ensuring Safe Travels: King County's Holiday Traffic Initiative
• Acadia Healthcare Faces Class Action Amid Significant Losses
• S&P Dow Jones Indices Reveals Results of 2024 DJSI Review
• Celebrating Entrepreneurial Success: The Impact of MBDA
• Village Super Market's Dividend Announcement and Growth Plans
• Digi International Welcomes New Executive Leaders to Board
• Transfusion Market Expected to Rise by $2.6 Billion: Insights
• CenterPoint Energy Announces Increased Quarterly Dividend Payout
• Shobha Launches Exciting Offers and Convenient Memberships
• ANSC Secures Key Approval for Upcoming Business Combination
• Barite Market Forecast: Growth Driven by Oil and AI Trends
• Contract Cleaning Services: Driving Growth with AI Innovation
• Lochmere Association Recognized for Eco-Friendly Excellence
• Fairholme Funds Announcement: December Dividend Details
• Empowering Change: Vigil for Clemency at the White House
• Boar's Head Reaches Settlement in Landmark Listeria Case
• Discover the SR6800 Window: Where History Meets Innovation
• Turkish Airlines Announces New Lounge at JFK's Terminal One
• AI Innovations Fuel Growth in the Analytical Standards Market
• Understanding the Seafood Market: Trends and Innovations
• Univest Securities Completes $2.7 Million Offering for LICN
• CubeSmart Declares Quarterly Dividend Increase for Shareholders
• Douglas Emmett Inc. Announces Cash Dividend for Shareholders
• Galderma's Breakthrough Approval of Nemluvio for Atopic Dermatitis